Pediatric Patents (Class 426/801)
  • Patent number: 6120814
    Abstract: This invention relates to a nutritional beverage substantially free of chemical pesticides, antibiotics, hormones, herbicides, non-genetically modified plants and chemical solvents that utilizes organic brown rice syrup as a major component and a source of calcium which is natural milk mineral, or calcium lactate gluconate and mixtures thereof. The beverage preferably also contains water soluble vitamins, oil soluble vitamins, flavors and organic protein. The use of brown rice syrup and natural milk mineral in a preferred embodiment of the beverage provides a beverage with a smooth texture, a pleasant taste and a light, refreshing mouthfeel. The beverage also has excellent physical stability over shelf life.
    Type: Grant
    Filed: February 22, 1999
    Date of Patent: September 19, 2000
    Assignee: Nature's One, Inc.
    Inventors: Jay C Highman, Jeffery W Liebrecht
  • Patent number: 6117461
    Abstract: A food composition containing from about 80 to about 98 parts by weight of a first plant material derived from fruit and/or vegetable juices, from about 1 to about 10 parts by weight of a second plant material derived from fruit and/or vegetable fiber, and from about 1 to about 10 parts by weight of enzyme material selected from the group consisting of amylase, protease, lipase, cellulase, and mixtures thereof. Preferably, the first and second materials are each dried before being combined, and the enzyme material is derived from at least one species of Aspergillus mold.
    Type: Grant
    Filed: April 30, 1997
    Date of Patent: September 12, 2000
    Inventor: Humbart D. Santillo, Jr.
  • Patent number: 6099871
    Abstract: Infant formula containing certain thickening agents useful for treating regurgitation. The thickening agent can be waxy corn starch, waxy rice starch, or a mixture thereof.
    Type: Grant
    Filed: May 3, 1996
    Date of Patent: August 8, 2000
    Assignee: Bristol-Myers Squibb Company
    Inventor: Sarah B. Martinez
  • Patent number: 6083934
    Abstract: A nutritional formulation containing an effective amount of Lacto-N-neoTetraose to simulate the growth and/or metabolic activity of Bifidobacterium is provided. A process of inhibiting bacterial infections caused by Bacteroides, Clostridium, and E. coli including the step of feeding the nutritional composition to a subject is also provided.
    Type: Grant
    Filed: March 19, 1999
    Date of Patent: July 4, 2000
    Assignee: Abbott Laboratories
    Inventors: Pedro A. Prieto, Terry A. Kroening
  • Patent number: 6077558
    Abstract: An emulsifying system for elemental diet compositions is provided that comprises a protein source that may be a extensively hydrolyzed protein, free amino acids, short-chain peptides, or a mixture thereof; a lipid source; a carbohydrate source; and an emulsifying system comprising an ocentyl succinic anhydride modified starch and an acetylated monoglyceride emulsifier. The composition may be prepared as a powder or liquid nutritional composition for formulas prepared for infant, pediatric and adult populations in need of an elemental diet. The invention provides a commercially acceptable product in terms of desired stability and physical characteristics and is particularly useful for hypoallergenic infant formula preparations.
    Type: Grant
    Filed: December 23, 1998
    Date of Patent: June 20, 2000
    Assignee: Bristol-Myers Squibb Company
    Inventor: John Euber
  • Patent number: 6077828
    Abstract: The present invention relates to methods and nutritional compositions for the prevention and treatment of cachexia and anorexia. The methods of the invention comprise administering a composition comprising effective amounts of .omega.-3 fatty acids such as alpha-linolenic acid, stearidonic acid, eicosapentaenoic acid, docosapentaenoic acid, docosahexaenoic acid or mixtures thereof; of branched-chain amino acids valine, leucine, isoleucine or mixtures thereof; with or without reduced levels of tryptophan and 5-hydroxytryptophan; and of antioxidant system selected from the group comprising beta-carotene, vitamin C, vitamin E, selenium, or mixtures thereof.
    Type: Grant
    Filed: April 24, 1997
    Date of Patent: June 20, 2000
    Assignee: Abbott Laboratories
    Inventors: Bonnie Chandler Abbruzzese, Mark Anthony McCamish, Frederick Oliver Cope, Stephen Joseph Demichele
  • Patent number: 6063433
    Abstract: A beverage mixture for infants and toddlers containing goat milk, rice milk and aloe vera juice and distilled water which is free of refined sugar and cow milk.
    Type: Grant
    Filed: August 14, 1996
    Date of Patent: May 16, 2000
    Inventors: Marguerite F. Benward, Wallace Benward
  • Patent number: 6051261
    Abstract: A staged fortification system and a method of providing fortification on a staged basis to infants involves feeding an infant a Vitamin C fortified juice when the infant is from 3 to 6 months of age, feeding the infant a Vitamin C and iron fortified juice when the infant is from 6 to 9 months of age, feeding the infant a Vitamin C, iron and zinc fortified juice when the infant is from 9 to 12 months of age, and feeding the infant a Vitamin C, iron, zinc and calcium fortified juice when the infant is 1 year of age and older. The staged fortification system provides appropriate vitamins and minerals which are needed at particular stages in the development of an infant.
    Type: Grant
    Filed: March 6, 1998
    Date of Patent: April 18, 2000
    Assignee: Gerber Products Company
    Inventors: Sandra J. Bartholmey, Jay A. Burnett, Reginald A. Berry, Delfino Marin Mendoza, Carlos Flores Rivera
  • Patent number: 6045854
    Abstract: A nutritional formulation containing at least one of the following oligosaccharides: from about 400 to about 3500 mg/L of 3-fucosyllactose; from about 200 to about 2200 mg/L of lacto-N-fucopentaose III; from about 100 to about 1500 mg/L of lacto-N-fucopentaose II; from about 100 to about 2500 mg/L of difucosyllactose; from about 500 to about 4500 mg/L of 2' fucosyllactose; from about 250 to about 3300 mg/L of lacto-N-fucopentaose I; from about 100 to about 900 mg/L of Lacto-N-neoTetraose; from about 50 to about 2300 mg/L of lacto-N-fucopentaose V; or from about 300 to about 2800 mg/L of lacto-N-tetraose.
    Type: Grant
    Filed: March 31, 1997
    Date of Patent: April 4, 2000
    Assignee: Abbott Laboraties
    Inventors: Pedro A. Prieto, Stephen J. Kirchner, Renee M. Erney
  • Patent number: 6039985
    Abstract: Refrigeration-shelf-stable ready-to-feed and concentrated infant formulas prepared through an ultra-pasteurization and/or pasteurization process, comprise per five fluid ounces from about 1.8 to about 6.3 grams of protein; from about 3.3 to about 15.9 grams of fat; from about 300 mg to about 3000 mg of linoleic acid; from about 250 to about 900 IU of Vitamin A; from about 40 to about 180 IU of Vitamin D; from about 0.7 to about 9 IU of Vitamin E; from about 4 to about 24 mcg of Vitamin K; from about 40 to about 300 mcg of Thiamine (Vitamin B1); from about 60 to about 450 mcg of Riboflavin (Vitamin B2); from about 35 to about 180 mcg of Vitamin B6; from about 0.15 to about 0.9 mcg of Vitamin B12; from about 250 to about 3150 mcg of Niacin; from about 4 to about 48 mcg of Folic Acid (Folacin); from about 300 to about 1500 mcg of Pantothenic Acid; from about 1.5 to about 13.
    Type: Grant
    Filed: May 4, 1999
    Date of Patent: March 21, 2000
    Assignee: Princeton Nutrition, L.L.C.
    Inventor: A. Reza Kamarei
  • Patent number: 6036992
    Abstract: Enteral formulas that contain long-chain polyunsaturated fatty acids (PUFAs) and a process for making such enteral compositions are described. More particularly, the invention relates to enteral compositions which provide long chain PUFAs arachidonic acid (AA) and docosahexaenoic acid (DHA) essentially free of cholesterol and may be derived from egg yolk lipids, and thus are predominantly in a phospholipid form. The process of making such a composition provides improved organoleptic and stability properties. Enteral compositions according to this invention may be used to feed infants, particularly pre-term infants, to promote neural development and development of visual acuity, and to reduce the incidence of necrotizing enterocolitis.
    Type: Grant
    Filed: March 16, 1999
    Date of Patent: March 14, 2000
    Assignee: Abbott Laboratories
    Inventors: David A. Borror, David V. Diodato, Debra L. Ponder, Margaret H. Dohnalek
  • Patent number: 6020015
    Abstract: Compositions containing human milk proteins, including the so-called host resistance factors of human milk, prepared by chemically synthesizing the human milk proteins or by genetic engineering techniques for producing recombinant human milk proteins, are useful for supplementing or enhancing the diet of infants, particularly very-low-birth-weight infants. The human milk proteins include the host resistance factors (HRF) found in human milk, such as lactoferrin (LF), lactoperoxidase (LP), lysozyme (LZ), immunoglobulin-A (IgA), alpha-lactalbumin, alpha, beta, kappa-caseins, and others. The compositions may also include components other than the human milk proteins useful for improved infant nutrition. In the utilization of the compositions of this invention, the compositions would be administered to an infant in at least an amount that the infant would receive if fed substantially only fresh human milk.
    Type: Grant
    Filed: September 6, 1991
    Date of Patent: February 1, 2000
    Inventor: Gerald E. Gaull
  • Patent number: 5997915
    Abstract: A composition for human or animal consumption for supplying folate which includes a natural isomer of reduced folate, such as (6S)-tetrahydrofolic acid, 5-methyl-(6S)-tetrahydrofolic acid, 5-formyl-(6S)-tetrahydrofolic acid, 10-formyl-(6R)-tetrahydrofolic acid, 5,10-methylene-(6R)-tetrahydrofolic acid, 5,10-methenyl-(6R)-tetrahydrofolic acid, 5-formimino-(6S)-tetrahydrofolic acid, and their polyglutamyl derivatives is disclosed. Such compositions include multivitamin preparations (with or without minerals and other nutrients); breakfast foods such as prepared cereals, toaster pastries and breakfast bars; infant formulas; dietary supplements and complete diet and weight-loss formulas and bars; animal feed (for example pet foods) and animal feed supplements (such as for poultry feed). The amount of the natural isomer of a reduced folate in a composition for human consumption can range between about 5% and about 200% of the daily requirement for folic acid per serving or dose.
    Type: Grant
    Filed: July 31, 1998
    Date of Patent: December 7, 1999
    Assignee: South Alabama Medical Science Foundation
    Inventors: Steven W. Bailey, June E. Ayling
  • Patent number: 5993885
    Abstract: A stabilizer system for nutritional formulas; especially liquid nutritional formulas. The stabilizer system is made up of a gel-forming carrageenan and a diacetyl tartaric acid ester of mono- and di-glycerides. The nutritional formula is formed of a protein source, a lipid source, a carbohydrate source, and the stabilizer system. The nutritional formula has improved color and physical stability.
    Type: Grant
    Filed: May 22, 1998
    Date of Patent: November 30, 1999
    Assignee: Nestec S.A.
    Inventors: Ershen Lin, Reinhard Behringer
  • Patent number: 5985338
    Abstract: The present invention relates generally to a method of producing plant proteins for use in nutritional products that have reduced levels of phytoestrogens, manganese or nucleotides. More specifically, this invention is directed to a method of using ion exchange technology to remove phytoestrogens, manganese or nucleotides from plant proteins. This invention is also directed to the plant protein product resulting from the inventive process and to nutritional products that use the plant protein product as a source of amino nitrogen.
    Type: Grant
    Filed: June 30, 1998
    Date of Patent: November 16, 1999
    Assignee: Abbott Laboratories
    Inventors: John D. Suh, Karin M. Ostrom, Louis I. Ndife, Paul S. Anloague, James N. Chmura, Andre Daab-Krzykowski, Paul W. Johns, Diane M. Garcia, Terrence B. Mazer, Fu-I Mei
  • Patent number: 5972393
    Abstract: A dehydrated acidified milk product is made by preparing an aqueous composition containing milk protein and having a dry matter content of from 10% to 40% by weight. The aqueous composition is inoculated with a strain of L. helveticus which exclusively forms lactic acid L(+) and a strain of S. thermophilus and fermented to obtain a fermented composition having a pH of from 4 to 5. The fermented composition is dried to obtain the dehydrated acidified product.
    Type: Grant
    Filed: October 23, 1992
    Date of Patent: October 26, 1999
    Assignee: Nectec S.A.
    Inventors: Ernst Beutler, Leuka Favre-Galliand, Johann Illi, Andreas Sutter
  • Patent number: 5962062
    Abstract: A milk having a formulated lipid composition wherein the lipids are lipids of lactic and vegetable origin which are, by weight, (i) from 30% to 40% milk fat lipids, (ii) from 30% to 40% of a first oil substance which have an oleic acid content in an amount greater than 60%, and (iii) from 1% to 30% of oil substance which provide n-3 and n-6 polyunsaturated fatty acids and so that triglyceride fatty acids of the lipids comprise 20% to 40% saturated fatty acids of lactic origin, 35% to 60% monounsaturated fatty acids, and 15% to 30% of n-3 and n-6 polyunsaturated in a ratio of n-6 to n-3 fatty acids of from 5:1 to 10:1.
    Type: Grant
    Filed: June 27, 1997
    Date of Patent: October 5, 1999
    Assignee: Nestec S.A.
    Inventors: Anne-Lise Carrie, Edward Fern, Mathilde Fleith, Armand Malnoe, Martin Vikas
  • Patent number: 5955138
    Abstract: Baby foods comprising water and celeriac root crown, Hamburg parsley root or a combination thereof and methods for preparation of such baby foods.
    Type: Grant
    Filed: October 31, 1996
    Date of Patent: September 21, 1999
    Assignee: Beech-Nut Nutrition Corporation
    Inventors: Richard C. Theuer, Richard F. Russo, Gerald E. Shaul
  • Patent number: 5942274
    Abstract: A human infant formula sufficient to meet the nutritional requirements of a human infant, comprising proteins having substantially the same amino acid sequence and biological properties as human alpha-lactalbumin and human beta-casein. The proteins may be produced from microorganisms, particularly E. coli. A recombinant DNA segment comprising a human milk protein encoding gene; a promoter sequence directing the transcription of the gene, where the promoter sequence is different from the promoter sequence for the gene in the human organism; and a terminator site for the human milk protein encoding gene. A microorganism containing a recombinant DNA segment comprising a human milk protein encoding gene; a promoter sequence directing the transcription of the gene; and a terminator site for the gene.
    Type: Grant
    Filed: June 19, 1998
    Date of Patent: August 24, 1999
    Inventor: Charles W. Slattery
  • Patent number: 5929109
    Abstract: The present invention relates to an agent for enhancing and stabilizing the activity of Bifidus factor, containing at least one member selected from the group consisting of ascorbic acid, hyposulfurous acid and acetic anhydride as the effective ingredient, and by preparing the agent singly or in combination with Bifidus factor as a food and drink type or as a composition of pharmaceutical type, intestinal microflora can be ameliorated. The agent can be used as a selective medium for assaying the number of bifidobacteria.
    Type: Grant
    Filed: October 3, 1997
    Date of Patent: July 27, 1999
    Assignee: Meiji Milk Products Company Limited
    Inventors: Hiroharu Mori, Kakuhei Isawa, Tsutomu Kaneko
  • Patent number: 5922766
    Abstract: This invention relates to a palatable elemental nutritional formula that is nutritionally complete for humans with specialized dietary needs. The nutritional of the present invention uses specific free amino acids to provide the source of amino nitrogen (protein equivalents) and a special blend of fats that provides 38 to 50% of the total Calories in a pleasant tasting formula. The nutritionally complete formula of this invention is useful for children having multiple protein allergies, short gut syndrome, sick gut, diarrhea and the like. More specifically, the nutritional product, in accordance with this invention, utilizes L-asparagine monohydrochloride and L-glutamine in place of L-aspartic acid and L-glutamic acid, respectively. In addition, the source of fat comprises soy, fractionated coconut oil (medium chain triglycerides), high oleic safflower oil and esterified glycerol emulsifiers.
    Type: Grant
    Filed: July 2, 1997
    Date of Patent: July 13, 1999
    Inventors: Phyllis J. B. Acosta, Marlene W. Borschel, Patricia A. Reynolds, Christopher T. Cordle, Geralyn O. Duska-McEwen
  • Patent number: 5916621
    Abstract: A whey protein dominant baby food is prepared that may contain hydrolysed food with a reduced threonine content. This food can be obtained by adding glycomacropeptide-free or glycomacropeptide-reduced whey powder and/or whey protein concentrate as the whey proteins usually used in the production of milk baby food.
    Type: Grant
    Filed: July 29, 1996
    Date of Patent: June 29, 1999
    Assignee: Milupa GmbH & Co. KG
    Inventors: Gilda Georgi, Gunther Sawatzki, Friedrich Schweikhardt
  • Patent number: 5906847
    Abstract: A milk substitute composition is prepared with whey solids or whey solids and added lactose by dissolving a whey solids powder in an aqueous medium containing calcium sequestering agent and carrageenate components at a temperature of approximately from 30.degree. C. to 65.degree. C. and then, in a second step, at the same temperature, a skimmed milk solids powder is dissolved in the whey-containing medium, and before and/or after dissolving the skimmed milk solids powder, the whey solids are allowed to soak in the aqueous liquid phase of the composition so prepared for from 10 minutes to 4 hours for hydrating the whey solids. When lactose is used, the amount of whey solids powder employed may be reduced by about half.
    Type: Grant
    Filed: September 23, 1997
    Date of Patent: May 25, 1999
    Assignee: Nestec S.A.
    Inventors: Hans Engel, Martinas Kuslys, Heinz Wyss
  • Patent number: 5906982
    Abstract: A nutritional formulation containing an effective amount of Lacto-N-neoTetraose to simulate the growth and/or metabolic activity of Bifidobacterium is provided. A process of inhibiting bacterial infections including the step of feeding the nutritional composition to a subject is also provided.
    Type: Grant
    Filed: March 31, 1997
    Date of Patent: May 25, 1999
    Assignee: Abbott Laboratories
    Inventors: Pedro A. Prieto, Terry A. Kroening
  • Patent number: 5902797
    Abstract: A nutritional supplement comprising approximately from about 5 to about 25 grams carbohydrate; approximately from about 1 to about 25 grams protein; and approximately from about 1 to about 10 grams fat, for use in treating low appetite that may result in weight loss, is described.
    Type: Grant
    Filed: November 10, 1997
    Date of Patent: May 11, 1999
    Assignees: Beth Israel Deaconess Medical Center, Medical Foods, Inc.
    Inventors: Stacey J. Bell, R. Armour Forse, Bruce R. Bistrian, Robert C. Jones
  • Patent number: 5902617
    Abstract: A baby formula is provided having enzymes added to imitate the effect of those present in normal breast milk, aiding digestion of protein, carbohydrate (simple and complex sugars), and lipid. The enzymes are either of procaryotic or eucaryotic origin, isolated from fermentation broth or tissue, or expressed from recombinant gene sequences. The enzymes are provided in a form for addition to the formula prior to feeding the infant or at the time of feeding. In the preferred form, the enzymes are provided in a form that is stable to storage in the formula, but active when the formula reaches the portion of the gastrointestinal tract where the formula would normally be digested. In the most preferred embodiment, the enzymes are provided in a matrix with an enteric coating that releases the enzyme in the upper portion of the intestine. Depending on the formulation, proteases, carbohydrate degrading enzymes such as alpha-amylase, lactase, fructase, and sucrase, or lipases, are added to the formulation.
    Type: Grant
    Filed: May 19, 1992
    Date of Patent: May 11, 1999
    Inventor: Patrea L. Pabst
  • Patent number: 5840361
    Abstract: A baby food composition is disclosed which contains one or more fructan-containing vegetables. The composition selectively stimulates colonic bifidobacteria in the infant. The fructan-containing vegetables can include, among others, Jerusalem Artichoke, Salsify, Burdock and mixtures thereof. The baby food compositions can be a mixed vegetable preparation that includes at lease one fructan-containing vegetables along with other vegetables or baby food preparations. Also disclosed are methods for using and methods for preparing the baby foods.
    Type: Grant
    Filed: April 9, 1997
    Date of Patent: November 24, 1998
    Assignee: Beech-Nut Nutrition Corporation
    Inventors: Richard C. Theuer, Mary Beth Cool
  • Patent number: 5837309
    Abstract: Product and process of making a baby food containing water, a food suitable for consumption by babies and a light fleshed vegetable which is a non-bleeding beet root. The method requires mixing water with a pureed food and the pureed non-bleeding beet root, cooking the mixture, and comminuting and straining the cooked food to produce a reduced beta-carotene level food.
    Type: Grant
    Filed: June 12, 1997
    Date of Patent: November 17, 1998
    Assignee: Beech-Nut Nutrition Corporation
    Inventor: Richard C. Theuer
  • Patent number: 5814363
    Abstract: A sterile, degassed milk pap containing milk and a swollen cereal product is prepared by mixing heated milk with a cereal product to swell the cereal product during mixing, and after which, the mixture is heated further so that vegetative microbes are destroyed, the further-heated mixture is degassed to avoid oxidation of the mixture, the degassed mixture is heated under ultra-high-temperature conditions to sterilize the mixture, and then, the sterilized mixture is cooled.
    Type: Grant
    Filed: December 19, 1994
    Date of Patent: September 29, 1998
    Assignee: Nestec S.A.
    Inventor: Holger Kuehner
  • Patent number: 5795611
    Abstract: A human infant formula sufficient to meet the nutritional requirements of a human infant, containing proteins having substantially the same amino acid sequence and biological properties as human alpha-lactalbumin and human beta-casein. The proteins may be produced from microorganisms, particularly E. coli. A recombinant DNA segment containing a human milk protein encoding gene; a promoter sequence directing the transcription of the gene, where the promoter sequence is different from the promoter sequence for the gene in the human organism; and a terminator site for the human milk protein encoding gene. A microorganism containing a recombinant DNA segment containing a human milk protein encoding gene; a promoter sequence directing the transcription of the gene; and a terminator site for the gene.
    Type: Grant
    Filed: December 20, 1989
    Date of Patent: August 18, 1998
    Inventor: Charles W. Slattery
  • Patent number: 5786008
    Abstract: Coated animal feed agglomerates such as pellets are made starting with uncoated agglomerates or pellets that may be formed of easily agglomerated or pelleted ingredients but which may be lacking in desirable nutritional or other ingredients. A binder such as a viscous aqueous gel is coated onto the uncoated agglomerates or pellets. Thereafter, the damp binder coated agglomerates or pellets are dusted with a powder containing ingredients having a substantial lactose content which usually are not amenable to being extruded. After the dusting powder has been applied, the coated and dusted pellets undergo a curing step before they are dried and cooled.
    Type: Grant
    Filed: February 25, 1997
    Date of Patent: July 28, 1998
    Assignee: Moorman Manufacturing Company
    Inventors: R. Kim Humphry, Basil D. Bevans
  • Patent number: 5780039
    Abstract: An orally-ingestible nutrition composition having improved taste comprises a low pH (<7.0) form of an amino acid selected from arginine, valine and compounds associated with the synthesis of polyamines. Preferred low pH forms are salts such as arginine phosphate and mixtures thereof with arginine citrate. Preferred nutrition composition also comprise encapsulated polyunsaturated fatty acid.
    Type: Grant
    Filed: April 23, 1992
    Date of Patent: July 14, 1998
    Assignee: Novartis Nutrition AG
    Inventors: Norman A. Greenberg, Candis Kvamme, Mary K. Schmidl
  • Patent number: 5766667
    Abstract: A process for producing a meat analogue comprising the steps of liquefying whole vegetables being about 70% to about 99% water, thereby eliminating the need for added water, and blending the liquefied whole vegetables with animal meat to form a blended beef block.
    Type: Grant
    Filed: December 31, 1996
    Date of Patent: June 16, 1998
    Inventor: Mitchell Hochman
  • Patent number: 5739407
    Abstract: The present invention relates to a DNA sequence encoding the human milk protein .beta.-casein or an analogue or variant thereof which has either the calcium binding activity of human .beta.-casein, or opioid activity, or angiotensin converting enzyme (ACE) inhibitory activity, or a combination of any two or three of these activities. The DNA sequence may optionally contain one or more intron sequences and permissive RNA splice signals. The DNA sequence is used in the production of recombinant human .beta.-casein, advantageously by means of production in transgenic non-human mammals such as bovine species. In one embodiment, the DNA sequence is inserted into a milk protein gene of a mammal such as a whey acidic protein (WAP) gene. The main use of the recombinant human .beta.-casein is as a constituent of infant formulae. It is contemplated that the recombinant human .beta.
    Type: Grant
    Filed: June 18, 1993
    Date of Patent: April 14, 1998
    Assignee: Symbicom aktiebolag
    Inventors: Sven Bergstrom, Olle Hernell, Bo Lonnerdal, Karin Hjalmarsson, Lennart Hanson, Jan Tornell, Mats Stromqvigt
  • Patent number: 5723166
    Abstract: Orange carrots have a beta-carotene content of 75-150 ppm. Orange carrots are commonly used in strained baby foods. The high beta-carotene content of orange carrots results in a high vitamin A statement on the product label and causes the product to have an orange color. White carrots and yellow carrots have a beta-carotene content of less than 10 ppm. White carrots and/or yellow carrots can be used in lieu of, or in combination with, orange carrots to control beta-carotene levels and the color of baby foods. White sweet potatoes can be used in lieu of, or in combination with, white carrots, orange carrots and orange sweet potatoes to control beta-carotene levels and the color of baby foods. The term white sweet potatoes refers to tubers of light colored flesh of the species Ipomea batata, of the morning glory family, Convolvulaceae.
    Type: Grant
    Filed: February 21, 1996
    Date of Patent: March 3, 1998
    Assignee: Beech-Nut Nutrition Corporation
    Inventors: Richard C. Theuer, Craig S. Boyer, Richard F. Russo, Gerald E. Shaul
  • Patent number: 5700590
    Abstract: An improved enteral formula containing ribo-nucleotide equivalents (RNA, mono-, di- and triphosphate nucleotides, nucleosides and adducts such as activated sugars) at a level of at least 10 mg/100 Kcal (kilocalorie) of formula. More specifically, an infant formula containing at least 10 milligrams of nucleotide equivalents per 100 Kcal of formula where the nucleotide equivalents consist of RNA; mono-, di-, and triphosphate esters of adenosine, cytidine, guanosine, and uridine, and the d-ribose adducts thereof; and wherein the weight ratio of said cytidine nucleotide equivalents to said uridine nucleotide equivalents is 1.5:1 to 2.6:1; of said cytidine nucleotide equivalent to said adenosine nucleotide equivalents is 2:1 to 3.9:1; and of said cytidine nucleotide equivalents to said guanosine nucleotide equivalents is 1.75:1 to 2.8:1, is disclosed. The formula comprises carbohydrates, lipids, proteins, vitamins and minerals and four (4) ribo-nucleotide equivalents at specific levels and ratios.
    Type: Grant
    Filed: January 11, 1996
    Date of Patent: December 23, 1997
    Assignee: Abbott Laboratories
    Inventors: Marc Leif Masor, James Lee Leach, Bruce Edward Molitor, John Durand Benson, Jeffrey H. Baxter
  • Patent number: 5700513
    Abstract: The present invention is a liquid nutritional product with improved physical stability comprising: (a) a liquid nutritional mixture containing fat at a concentration sufficient to have the liquid nutritional mixture be susceptible to creaming and containing suspended minerals present at a concentration sufficient to have the liquid nutritional mixture be susceptible to sedimentation; (b) a carrageenan/microcrystalline cellulose/carboxymethyl cellulose additive composition comprising: (i) iota-carrageenan present in an amount of about 100-800 ppm of the liquid nutritional product; (ii) a mixture of microcrystalline cellulose/carboxymethyl cellulose, the mixture present in an amount of from about 600-3000 ppm of the liquid nutritional product. In a preferred embodiment, microcrystalline cellulose is present in a range of from about 1000 ppm to about 2500 ppm, while the iota-carrageenan is present in a range of from about 100 ppm to about 300.
    Type: Grant
    Filed: January 19, 1996
    Date of Patent: December 23, 1997
    Assignee: Abbott Laboratories
    Inventors: Rohini Prakash Mulchandani, Mohamed Ibrahim Mahmoud
  • Patent number: 5685990
    Abstract: A dispersion having an aqueous phase is filtered by a purality of membranes connected to pass the retentate or a portion of the retentate from one membrane step is used for feeding the one or more succeeding steps, and the permeate resulting from the plurality of membranes is subjected to a concentration step to produce a concentrate containing an increase concentration of dry matter, which is returned as a portion of the feeding dispersion to one or more of the plurality of membranes. The system provided with the membranes and concentration units and recirculation conduits is also disclosed.
    Type: Grant
    Filed: October 28, 1994
    Date of Patent: November 11, 1997
    Assignee: MD Foods A.M.B.A.
    Inventors: Aksel Saugmann, Erik Krabsen, Niels Klausen Ottosen
  • Patent number: 5656310
    Abstract: A process for preparing a food supplement is disclosed. In the first step of this process, at least two different food materials are juiced either together or separately to provide a juice fraction and a fiber fraction. The juice fraction is dried to produce a powder. The fiber fraction is dried. Thereafter, from about 80 to about 98 parts of the dried juice fraction, from about 1 to about 10 parts of the dried fiber fraction, and from about 1 to about 10 parts of a specified mixture of enzymes is mixed to provide the supplement.
    Type: Grant
    Filed: October 2, 1992
    Date of Patent: August 12, 1997
    Inventor: Humbart D. Santillo, Jr.
  • Patent number: 5641759
    Abstract: The present invention relates to a method and composition for animal husbandry comprising administering to livestock and other animals at least one composition selected from the group consisting of a caramel composition comprising a high content of fructose oligosaccharides, termed sucrose thermal oligosaccharides (STO), and a product comprising sucrose thermal kestoses. The growth of livestock and other animals may be greatly increased by administering STO caramel or sucrose thermal kestoses. The compositions alter specific microflora within the gastrointestinal tract to enhance the health of the animal by increasing the numbers of bifidobacteria and lactobacilli, and decreasing the numbers of undesirable microorganisms.
    Type: Grant
    Filed: May 26, 1993
    Date of Patent: June 24, 1997
    Assignee: Purdue Research Foundation
    Inventors: John A. Patterson, Geoffrey N. Richards
  • Patent number: 5607840
    Abstract: A protein hydrolyzate is produced from mucosa tissue of pigs, cattle or sheep by providing an aqueous mixture of the tissue, hydrolyzing the tissue with a proteolytic enzyme at a salt concentration of less than 0.1 molar to produce a digest solution containing a protein hydrolyzate and polyanions including heparin, adsorbing the polyanions on an anion exchange resin, recovering the anion exchange resin containing adsorbed polyanions to provide a digest solution containing less than 2.9 u/ml residual heparin and recovering the protein hydrolyzate from the digest solution by screening or dehydration. The protein hydrolyzate contains less than 15% ash, between 9.5 and 11.5% total Kjeldahl nitrogen and between 5.0 and 7.0% alpha amino nitrogen. The protein hydrolyzate may be used in nutritional formulations such as to promote weight gain in newly weaned livestock and in medical formulations such as peritoneal dialysis fluids and formulations for use in enteral and parenteral mutrition.
    Type: Grant
    Filed: April 8, 1994
    Date of Patent: March 4, 1997
    Assignees: Celsus, Inc., Consolidated Nutrition, L.C.
    Inventors: Cornelius L. Van Gorp, Frederick Vosburgh, Robert L. Schubert, II
  • Patent number: 5601860
    Abstract: The invention disclosed herein comprises fat compositions primarily for use in nutritionally complete infant formulas in which the constituent palmitic acid oils and lauric acid oils are corandomized. The invention additionally includes such corandomized fat compositions with medium-chain triglycerides added, particularly for use in nutritional products for preterm or low birthweight infants. The invention further includes such fat compositions in which the constituent palmitic acid oils and oleic acid oils are corandomized. Such corandomization of two or more oils yields a mixture of triglycerides having a substantially different chemical makeup than that of the native oils themselves or than the native oils when randomized individually. Corandomization of the palmitic acid oils and the lauric acid oils or of the palmitic acid oils and the oleic acid oils affords an economical means of providing a very highly absorbed fat composition.
    Type: Grant
    Filed: May 13, 1994
    Date of Patent: February 11, 1997
    Assignee: American Home Products Corporation
    Inventors: Eric L. Lien, Rudolph M. Tomarelli
  • Patent number: 5602109
    Abstract: An improved enteral nutritional formula containing ribo-nucleotide equivalents (RNA, mono-, di- and triphosphate nucleotides, nucleosides and adjuncts such as activated sugars) at a level of at least 10 mg/100 Kcal (kilocalorie) of formula is disclosed. The formula comprises carbohydrates, lipids, proteins, vitamins and minerals and four (4) ribo-nucleotide equivalents at specific levels and ratios. The invention also discloses novel methods of production and analytical techniques. This invention also provides a dietary formula that enhances the immune system and alleviates diarrhea.
    Type: Grant
    Filed: January 10, 1994
    Date of Patent: February 11, 1997
    Assignee: Abbott Laboratories
    Inventors: Marc L. Masor, Milo D. Hilty
  • Patent number: 5591446
    Abstract: A method for atopy prophylaxis involves administering an agent comprising .gamma.-linolenic acid, dihomo-.gamma.-linolinic acid, the physiologically compatible salts, esters, amides, phospholipids, glycolipids thereof, and/or prostaglandin E.sub.1 (PGE.sub.1), PGE.sub.1 derivatives, PGE.sub.1 analogs to preimmunocompetent humans to prevent the occurrence of atopy. These agents are typically contained in a baby food or are supplied to the baby concurrently. These foods may contain one or more thymus hormones. The use of PGE.sub.1, its derivatives and analogs and the physiologically compatible esters, amides, phospholipids and glycolipids thereof in a pharmacologically effective dosage form for the topical or inhalative treatment of acute manifest atopy in the dermal and mucosal areas. These substances are preferably used in combination with .gamma.-linolinic acid, and dihomo-.gamma.-linolinic acid, and/or the physiologically compatible salts, esters, amides, phospholipids and glycolipids thereof.
    Type: Grant
    Filed: April 11, 1995
    Date of Patent: January 7, 1997
    Assignee: Beiersdorf, A.G.
    Inventors: Bodo C. Melnik, Gerd Plewig
  • Patent number: 5589357
    Abstract: Disclosed is a milk protein partial hydrolysate prepared by enzymatic hydrolysis and infant formula prepared therefrom. The hydrolysate has reduced antigenicity and is prepared from a mixture of whey protein and casein wherein the degree of hydrolysis is between 4 and 10%.
    Type: Grant
    Filed: November 21, 1994
    Date of Patent: December 31, 1996
    Assignee: Bristol-Myers Squibb Company
    Inventors: Sarah B. Martinez, H. Lee Leary, Jr., Debra J. Nichols
  • Patent number: 5569483
    Abstract: A degradation product of a polysaccharide derivative comprising a mixture of oligomers of the polysaccharide derivative, the majority of said oligomers having a molecular weight such that the oligomer conforms to a rod-like configuration.
    Type: Grant
    Filed: June 7, 1994
    Date of Patent: October 29, 1996
    Assignee: Alko Group Ltd.
    Inventors: Maritta Timonen, ChoKyun Rha, Timo Vaara, Lindsey Bagley, Sarah Bosdet, Michael Lindley, Tarja Lahtinen, Marja Turunen, Martti Vaara
  • Patent number: 5550106
    Abstract: A low buffer nutritional composition which is useful to reduce the incidence of colonization of pathogenic bacteria.
    Type: Grant
    Filed: March 4, 1994
    Date of Patent: August 27, 1996
    Assignee: Bristol-Myers Squibb Company
    Inventors: Bryon W. Petschow, Yung-Hsiung Lee
  • Patent number: 5543162
    Abstract: An insoluble polymeric capsule comprising at least two polymeric components, wherein one of said components is a hydrophilic colloid, and another of said components comprises a degradation product of a cellulose derivative, the degradation product comprising a mixture of oligomers, a majority of said oligomers having a degree of polymerization such that the oligomers conform to a rod-like configuration.
    Type: Grant
    Filed: November 23, 1994
    Date of Patent: August 6, 1996
    Assignee: Alko Group Ltd.
    Inventors: Maritta Timonen, Chokyun Rha
  • Patent number: 5492899
    Abstract: An improved enteral nutritional formula containing ribo-nucleotide equivalents (RNA, mono-, di- and triphosphate nucleotides, nucleosides and adjuncts such as activated sugars) at a level of at least 10 mg/100 Kcal (kilocalorie) of formula is disclosed. The formula comprises carbohydrates, lipids, proteins, vitamins and minerals and four (4) ribo-nucleotide equivalents at specific levels and ratios. The invention also discloses novel methods of production and analytical techniques. An infant formula containing cytidine nucleotide equivalents in the range of 29 to 39 mg/liter of formula, uridine nucleotide equivalents in the range of 15 to 20 mg/liter of formula, adenosine nucleotide equivalents in the range of 10 to 15 mg/liter of formula and guanosine nucleotide equivalents in the range of 14 to 20 mg/liter of formula provides a dietary formula that enhances the immune system and alleviates diarrhea.
    Type: Grant
    Filed: January 10, 1994
    Date of Patent: February 20, 1996
    Assignee: Abbott Laboratories
    Inventors: Marc L. Masor, James L. Leach, Bruce E. Molitor, John D. Benson, Jeffrey H. Baxter
  • Patent number: 5480674
    Abstract: A flavor composition for an oral electrolyte hydrate solution comprises ethyl esters, citrus oil concentrates, and sweet and fruity flavor components. Ethyl esters are used instead of more typical allyl esters because they are innocuous in dehydrated children whose health may be compromised. The ethyl esters are selected from ethyl acetate, ethyl butyrate, ethyl caproate, ethyl 2-methylbutyrate and ethyl heptanoate. The flavor composition provides an innocuous tutti-frutti (bubble gum) flavor to the oral electrolyte hydrate solution.
    Type: Grant
    Filed: November 29, 1994
    Date of Patent: January 2, 1996
    Assignee: Firmenich Incorporated
    Inventor: Robert J. Peterson